pharm exam 3
Antagonist
Antagonist
Julia Skellie · 178問 · 2年前Antagonist
Antagonist
178問 • 2年前Monitors
Monitors
Julia Skellie · 144問 · 2年前Monitors
Monitors
144問 • 2年前Positioning
Positioning
Julia Skellie · 88問 · 2年前Positioning
Positioning
88問 • 2年前arterial vasodilators, peripheral vasodilators, CCB
arterial vasodilators, peripheral vasodilators, CCB
Julia Skellie · 122問 · 2年前arterial vasodilators, peripheral vasodilators, CCB
arterial vasodilators, peripheral vasodilators, CCB
122問 • 2年前AntiArrhythmics
AntiArrhythmics
Julia Skellie · 70問 · 2年前AntiArrhythmics
AntiArrhythmics
70問 • 2年前just dont forget:
just dont forget:
Julia Skellie · 8問 · 2年前just dont forget:
just dont forget:
8問 • 2年前Rspiratory
Rspiratory
Julia Skellie · 42問 · 2年前Rspiratory
Rspiratory
42問 • 2年前Monitored and Conscious Sedation
Monitored and Conscious Sedation
Julia Skellie · 48問 · 2年前Monitored and Conscious Sedation
Monitored and Conscious Sedation
48問 • 2年前Emergence
Emergence
Julia Skellie · 29問 · 2年前Emergence
Emergence
29問 • 2年前PACU
PACU
Julia Skellie · 14問 · 2年前PACU
PACU
14問 • 2年前Random
Random
Julia Skellie · 19問 · 2年前Random
Random
19問 • 2年前Pharm Induction Agents
Pharm Induction Agents
Julia Skellie · 58問 · 2年前Pharm Induction Agents
Pharm Induction Agents
58問 • 2年前Laparoscopic Surgery
Laparoscopic Surgery
Julia Skellie · 39問 · 2年前Laparoscopic Surgery
Laparoscopic Surgery
39問 • 2年前Hematology Coagulation
Hematology Coagulation
Julia Skellie · 66問 · 2年前Hematology Coagulation
Hematology Coagulation
66問 • 2年前LIVER
LIVER
Julia Skellie · 84問 · 2年前LIVER
LIVER
84問 • 2年前ENT
ENT
Julia Skellie · 17問 · 2年前ENT
ENT
17問 • 2年前Opioids
Opioids
Julia Skellie · 18問 · 2年前Opioids
Opioids
18問 • 2年前MH
MH
Julia Skellie · 32問 · 2年前MH
MH
32問 • 2年前NeuroSurg
NeuroSurg
Julia Skellie · 20問 · 2年前NeuroSurg
NeuroSurg
20問 • 2年前Burns
Burns
Julia Skellie · 89問 · 2年前Burns
Burns
89問 • 2年前Regional
Regional
Julia Skellie · 11問 · 2年前Regional
Regional
11問 • 2年前問題一覧
1
non-opioid analgesic techniques lack respiratory depression, physical dependence and abuse not regulated under controlled substances act multimodal adjuvants: NSAID magnesium lidocaine lyrica
2
acids
3
low with minimal tissue binding
4
liver
5
alter binding and metabolism more unbound drug more side effects
6
prolongs half life lower dose
7
aspirin
8
celecoxib
9
naproxen
10
cardiovascular risks: MI HTN stroke HF
11
1. inhibit platelet aggregation 2. decrease renal blood flow 3. loss of gastric mucosa secretion - GI bleed, peptic ulcers
12
1. anti inflammatory 2. antipyretic 2. analgesic
13
30mg
14
GI
15
COX 2- celecoxib
16
1. cardiovascular risk- htn, hf, mi (more likely with cox 2) 2. respiratory- bronchospaspm, nasal polyps, dysnpnea, asthma 3. GI- peptic ulcer 4. hematologic- inhibits platelet aggregation- bleeding risk
17
fatigue weight gain myxedema depression
18
muscle wasting weight loss hot exopathlamos
19
levothyroxine
20
liothyronine has multiple dosing intervals, more potent, requires frequent lab work levothyroxine- once a day
21
T4 is converted to T3 intracellulary
22
empty stomach gel form available if intolerant
23
7 day half life 4-6 weeks to steady state
24
1. antithryoid: interfere with synthesis of TH 2. ionic inhibitors: block iodide transport mechanism 3. high concentration iodine: decrease release of TH from gland and decrease synthesis 4. radioactive iodine: ionizing radiation to damage gland
25
beta blockers CCB
26
carbimazole methimazole porpylthiouracil PTU
27
propranolol nadolol
28
thiourylenes
29
propylthioruracil
30
bind and inhibit peroxidase enzyme preventing iodine organification (iodine reaction with tyrosyl residue of thyroglobulin) inhibiting formation of thyroid horomones
31
propylthioruracil inhibits peripheral deiodination of T4 to T3 and methimazole does not
32
1. agranulocytosis 2. liver function
33
quantity of bound iodine increases iodide has the capacity to limit its own transport: negative feedback inhibits release of TH- rapid and effective in severe thyrotoxicosis thyroid gland becomes less vascular, cells become smaller and firmer reaccumulates in the follicles
34
rapidly and efficiently trapped by thyroid and deposited into the colloid of the follicles beta particles are emitted that destroy parenchymal cells of the thyroid
35
propylthioruracil radioactive dyes BB or CCB for tachydysththmias dexamethasone 10mg supportive measures: cooling or sedation
36
block thyroid hormone release as a result of the iodide released from the dyes inhibit T4 to T3 conversion
37
inhibit conversion of T4 to T3
38
suppression of the hypothalamic pituitary adrenal axis weight gain skeletal muscle wasting
39
anti-inflammatory effects
40
dexamethasone least: cortisol
41
cortisol attached to cytoplasmic receptors to enhance or suppress changes in the transcription of DNA and protein synthesis 2 receptors: mineralocorticoid: sodium and water retention: aldosterone -distal renal tubules, colon, salivary glands, hippocampus glucocorticoid: cortisol -widely distributed
42
allergy asthma antiemetic replacement therapy for deficient state: Addison anti-inflammatory acute adrenal insufficiency analgesia cerebral edema aspiration pneumonitis (laryngospasm) immunosuppression post intubation laryngeal edema- to de-swell or prevent myasthenia gravis arthritis